StockNews.com Begins Coverage on Edap Tms (NASDAQ:EDAP)

Investment analysts at StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note issued to investors on Monday. The firm set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Price Performance

Edap Tms stock opened at $2.50 on Monday. The firm has a market cap of $92.76 million, a price-to-earnings ratio of -3.85 and a beta of 0.36. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a fifty-two week low of $2.00 and a fifty-two week high of $8.50. The firm has a fifty day moving average price of $2.36 and a two-hundred day moving average price of $2.72.

Institutional Trading of Edap Tms

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EDAP. Illumine Investment Management LLC bought a new stake in Edap Tms during the fourth quarter worth about $50,000. BNP Paribas Financial Markets grew its stake in shares of Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 4,400 shares during the last quarter. Jane Street Group LLC grew its stake in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares during the last quarter. Millennium Management LLC grew its stake in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 33,558 shares during the last quarter. Finally, Orion Capital Management LLC grew its stake in shares of Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after purchasing an additional 6,600 shares during the last quarter. Institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.